Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if changes in ocular signs and symptoms occur in
patients with ocular hypertension or glaucoma when they switch from latanoprost 0.005%
(Xalatan) to preservative free Tafluprost eye drops.